BNP Paribas Financial Markets’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,935
| Closed | -$3.19K | – | 3633 |
|
|
2022
Q1 | $3.19K | Sell |
1,935
-2,498
| -56% | -$4.12K | ﹤0.01% | 3309 |
|
|
2021
Q4 | $10.6K | Buy |
4,433
+705
| +19% | +$1.69K | ﹤0.01% | 3242 |
|
|
2021
Q3 | $20.4K | Buy |
3,728
+2,941
| +374% | +$16.1K | ﹤0.01% | 3036 |
|
|
2021
Q2 | $5.86K | Sell |
787
-1,012
| -56% | -$7.53K | ﹤0.01% | 3191 |
|
|
2021
Q1 | $14.6K | Sell |
1,799
-387
| -18% | -$3.14K | ﹤0.01% | 3226 |
|
|
2020
Q4 | $19.9K | Sell |
2,186
-405
| -16% | -$3.69K | ﹤0.01% | 3194 |
|
|
2020
Q3 | $28.7K | Buy |
2,591
+2,205
| +571% | +$24.4K | ﹤0.01% | 3081 |
|
|
2020
Q2 | $2.87K | Sell |
386
-3,123
| -89% | -$23.2K | ﹤0.01% | 3512 |
|
|
2020
Q1 | $21.6K | Buy |
3,509
+1,857
| +112% | +$11.4K | ﹤0.01% | 3278 |
|
|
2019
Q4 | $8.29K | Buy |
1,652
+1,402
| +561% | +$7.04K | ﹤0.01% | 3478 |
|
|
2019
Q3 | $1.88K | Buy |
250
+237
| +1,823% | +$1.78K | ﹤0.01% | 3725 |
|
|
2019
Q2 | $151 | Buy |
+13
| New | +$151 | ﹤0.01% | 3838 |
|